Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901848 · ClinicalTrials.gov registry record · Phase 2
CPT and Smoking Cessation
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT01901848: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT01901848 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01901848, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
Posttraumatic stress disorder (PTSD) and cigarette smoking are both associated with significant impairment in Veterans and cost to the Veterans' Affairs (VA) system. Though research suggests smoking is linked with PTSD symptoms, existing smoking cessation treatments targeting PTSD smokers do not include PTSD treatment. The purpose of this study is to examine a treatment that combines evidence based treatment for PTSD (cognitive processing therapy, or CPT) with smoking cessation treatment for PTSD and a mobile text messaging program. The study objectives are to evaluate feasibility of the treatment and to examine effectiveness of CPT and smoking cessation treatment combined compared to smoking cessation treatment without CPT. Fifty Veteran smokers with PTSD will participate in fourteen study sessions, ending with the final follow-up session six months after the scheduled quit date.
Interventions
- DRUG Bupropion
- BEHAVIORAL Cognitive Processing Therapy (CPT)
- DRUG nicotine replacement therapy (NRT)
- BEHAVIORAL Integrated Care for Smoking Cessation (ICSC)
- BEHAVIORAL smokefreeVET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2013-12-11 |
| Est. Completion | 2017-07-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01901848
The ClinicalTrials.gov registry entry for NCT01901848 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupropion is the first listed.
NCT01901848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01901848 about?
NCT01901848 is a clinical study titled "CPT and Smoking Cessation". Posttraumatic stress disorder (PTSD) and cigarette smoking are both associated with significant impairment in Veterans and cost to the Veterans' Affairs (VA) system. Though research suggests smoking is linked with PTSD symptoms, existing smoking cessation treatments targeting PTSD smokers do not inc...
What is the current status of trial NCT01901848?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2013-12-11. Estimated completion is 2017-07-30.
What interventions are being tested in trial NCT01901848?
The interventions under investigation include: Bupropion (DRUG), Cognitive Processing Therapy (CPT) (BEHAVIORAL), nicotine replacement therapy (NRT) (DRUG), Integrated Care for Smoking Cessation (ICSC) (BEHAVIORAL), smokefreeVET (BEHAVIORAL).
Who is sponsoring clinical trial NCT01901848?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.